2,4-Dimethyl-2-pentenoic acid
Common Name: |
2,4-Dimethyl-2-pentenoic acid |
IUPAC Name: |
2,4-dimethylpent-2-enoic acid |
Molecular Formula: |
C7H12O2 |
SMILES: |
CC(C)C=C(C)C(=O)O |
Inchi: |
1S/C7H12O2/c1-5(2)4-6(3)7(8)9/h4-5H,1-3H3,(H,8,9) |
Inchi Key: |
DMHLGGQHOSTMJG-UHFFFAOYSA-N |
Cas No: |
3876-52-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
128.17 |
Mass (g/mol) |
128.084 |
Molar Refractivity |
37.06 |
Net Charge |
-1 |
HBD |
1 |
HBA |
2 |
Rt Bonds |
2 |
Rings |
|
TPSA |
37.30 |
Hetero Atoms |
2 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
217.00 to 218.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.052 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.57 |
LogP |
1.673 |
iLOGP |
1.79 |
XLOGP3 |
1.75 |
WLOGP |
1.67 |
MLOGP |
1.52 |
ESOL Log S |
-1.61 |
ESOL Solubility (mg/ml) |
3.18 |
ESOL Solubility (mol/l) |
0.025 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.15 |
Ali Solubility (mg/ml) |
0.91 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-0.51 |
Silicos-IT Solubility (mg/ml) |
39.2 |
Silicos-IT Solubility (mol/l) |
0.31 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.84 |
Bioavailability Score |
0.85 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.537 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.673 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |